Platelet aggregation studies in coronary artery disease. Past 4. Effect of aspirin.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Atherosclerosis

• Publication date

  1978-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0021-9150(78)90162-4PMID 728235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of acute myocardial ischaemia on platelet aggregation in the coronary sinus and aorta in dogs.

  2009cited by this paper
• Imaging platelet deposition with 111In-labeled platelets in coronary artery bypass grafts in dogs.

  1978cited by this paper
• Studies on the role of chronic propranolol therapy in altering platelet aggregation in coronary disease patients before, during and after acute ischemia

  1978cited by this paper
• Studies of the Release from Human Platelets of the Growth Factor for Cultured Human Arterial Smooth Muscle Cells

  1978cited by this paper
• Platelet Aggregation in the Cerebral Microcirculation: Effect of Aspirin and Other Agents

  1977cited by this paper
• Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.

  1976cited by this paper
• The mode of action of aspirin and similar compounds.

  1976cited by this paper
• The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH.

  1976cited by this paper
• Thromboxanes: selective biosynthesis and distinct biological properties.

  1976cited by this paper
• Inhibition of Human and Animal Platelet Adhesiveness to Glass Bead Columns by Adenosine, Dipyridamole, Chlorpromazine and Acetylsalicylic Acid

  1976cited by this paper
• Platelet Aggregation in Partially Obstructed Vessels and its Elimination with Aspirin

  1976cited by this paper
• Aspirin and coronary heart disease: findings of a prospective study.

  1975cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper
• Release of adenosine from human hearts during angina induced by rapid atrial pacing.

  1974cited by this paper
• A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction

  1974cited by this paper
• Platelet Function Studies in Coronary Artery Disease

  1973cited by this paper
• Stress and the Induction of Intravascular Platelet Aggregation in the Heart

  1973cited by this paper
• Intravascular Platelet Aggregation in the Heart Induced by Stress

  1973cited by this paper
• Effect of Experimental Coronary Thrombosis upon Platelet Kinetics

  1973cited by this paper
• Platelet studies in patients with coronary artery disease and in their relatives.

  1972cited by this paper
• Platelets and Thrombosis in Acute Myocardial Infarction

  1972cited by this paper
• Refractory state of platelet aggregation with major operations.

  1971cited by this paper
• Use of technetium-labelled human albumin microspheres for studies of the coronary circulation.

  1971cited by this paper
• The Effect of Ischemia and Alterations of Heart Rate on Myocardial Potassium Balance in Man

  1970cited by this paper
• Platelet Function and Myocardial Infarction

  1969cited by this paper
• Coagulation Tests and Platelet Economy in Atherosclerotic and Control Subjects

  1962cited by this paper
• Acetylsalicylic acid, possible preventive of coronary thrombosis.

  1950cited by this paper

• The prevalence and associated factors of aspirin resistance in JAK2V617F-mutated essential thrombocythemia and polycythemia vera.

  2025cites this paper
• Aspirin Resistance and Stroke

  2018cites this paper
• Hemorheological abnormalities and their associations with coronary blood flow in patients with cardiac syndrome X: a comparison between males and females

  2017cites this paper
• Prevalence of aspirin resistance in coronary artery disease among Indian patients

  2016cites this paper
• A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models

  2016cites this paper
• High On-Treatment Platelet Reactivity in Peripheral Endovascular Procedures

  2014cites this paper
• Antiplatelet therapies: aspirin at the heart of new directions.

  2014cites this paper
• Prevalence of Aspirin Resistance and Clinical Characteristics in Patients with Cerebral Infarction

  2013cites this paper
• Poor response to antiplatelet drugs. An important issue in drug-eluting stents.

  2013cites this paper
• Toward a genomic definition of aspirin resistance.

  2013cites this paper
• Aspirin and aspirin resistance in coronary artery disease.

  2013cites this paper
• Current Status of Pharmacogenetics in Antithrombotic Drug Therapy

  2012cites this paper
• Resistance to aspirin and clopidogrel therapy

  2011cites this paper
• Aspirin Resistance

  2009cites this paper
• Analgesics and risk of coronary and other death in middle-aged men in eastern Finland.

  2009cites this paper
• Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed.

  2009cites this paper
• MechanIsMs of actIon of aspIrIn

  2009cites this paper
• The role of aspirin in cardiovascular prevention: implications of aspirin resistance.

  2008cites this paper
• Aspirin resistance in atherosclerosis

  2008cites this paper
• Prevalence and Clinical Characteristics of Aspirin Resistance in the Patients with Type 2 Diabetes Mellitus

  2008cites this paper
• OFFICIAL PUBLICATION FOR THE FEDERATION OF MEDICAL SOCIETIES OF HONG KONG

  2007cites this paper
• Aspirin resistance and atherothrombosis.

  2007cites this paper
• The genetics of aspirin resistance

  2007cites this paper
• Significance of aspirin and clopidogrel resistance in patients undergoing percutaneous coronary interventions.

  2007cites this paper
• Aspirin Resistance: Is it Real and Does it Matter?

  2007cites this paper
• Descritores: Aspirina. Resistência a drogas. Doenças cardiovasculares, prevenção & controle. Trombose, prevenção & controle. Descriptors: Aspirin. Drug resistance. Cardiovascular diseases, prevention & control. Thrombosis, prevention & control.

  2007cites this paper
• Resistência à aspirina e aterotrombose

  2007cites this paper
• Descriptors: Aspirin. Drug resistance. Cardiovascular diseases, prevention & control. Thrombosis, prevention & control. Descritores: Aspirina. Resistência a drogas. Doenças cardiovasculares, prevenção & controle. Trombose, prevenção & controle.

  2007cites this paper
• Variable response to antiplatelet therapy: what does it mean to clinicians?

  2007cites this paper
• Aspirin resistance.

  2006cites this paper
• Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance.

  2006cites this paper
• Clinical applications of antiplatelet therapy.

  2006cites this paper
• Antiplatelet resistance with aspirin and clopidogrel: Is it real and does it matter?

  2006cites this paper
• ANTIPLATELET THERAPY IN PERIPHERAL OCCLUSIVE ARTERIAL DISEASE

  2006cites this paper
• Aspirin and Clopidogrel: Efficacy, Treatment, and Resistance in Coronary Artery Disease

  2005cites this paper
• Prevalence, profile, predictors, and natural history of aspirin resistance measured by the ultegra rapid platelet function assay- asain patients with coronary artery disease

  2005cites this paper
• [Aspirin resistance].

  2005cites this paper
• Resistance to antiplatelet drugs: current status and future research

  2005cites this paper
• Use of the platelet function analyser (PFA‐100®) to quantify the effect of low dose aspirin in patients with ischaemic heart disease

  2005cites this paper
• Resistencia a la aspirina

  2005cites this paper
• Aspirin resistance and atherothrombotic disease.

  2005cites this paper
• Aspirin

  2004cites this paper
• Aspirin

  2004cites this paper
• Aspirin. The antiplatelet effect of aspirin.

  2004cites this paper
• Aspirin

  2004cites this paper
• The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

  2004cites this paper
• Aspirin. Aspirin does not alter native blood viscosity.

  2004cites this paper
• Aspirin

  2004cites this paper
• Aspirin

  2004cites this paper
• Aspirin

  2004cites this paper
• Platelets and anti-platelet therapy.

  2003cites this paper
• Aspirin Resistance in Cardiovascular Disease: A Review of Prevalence, Mechanisms, and Clinical Significance

  2002cites this paper
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

  2001cites this paper
• Carl John Pepine, MD: a conversation with the editor.

  2001cites this paper
• Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects

  1998cites this paper
• PLASMA THROMBOXANE B 2 AND LEUKOTRIENE B 4 LEVELS IN PATIENTS WITH CORONARY ATHEROSCLEROSIS

  1994cites this paper
• Platelet aggregability and in vivo platelet deposition in patients with ischemic cerebrovascular disease--evaluation by indium-111-platelet scintigraphy.

  1989cites this paper
• Pilot study of the effect of raubasine on platelet biological activity.

  1986cites this paper
• Eicosanoids and the coronary circulation.

  1986cites this paper
• Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina.

  1985cites this paper
• Contributory role of platelets in various manifestations of ischemic heart disease.

  1985cites this paper
• Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy.

  1984cites this paper
• Thromboxane B2, 6-keto-PGF1α, PGE2, PGF2α, and PGA1 plasma levels in arteriosclerosis obliterans: Relationship to clinical manifestations, risk factors, and arterial pathoanatomy

  1984cites this paper
• Plasma platelet products and exercise-induced myocardial ischemia.

  1983cites this paper
• Platelet Release Reaction and Prostaglandin Pathway Activation in Angina Patients during Exercise: Effect of Indobufen

  1983cites this paper
• Platelet Hyperaggregability in Ischemic Cerebrovascular Disease and Effects of Aspirin

  1982cites this paper
• Prevention of in vivo Platelet Aggregation by Indobufen in Angina Patients during Exercise

  1981cites this paper
• Role of blood platelets and prostaglandins in coronary artery disease.

  1981cites this paper
• A survey of 246 suggested coronary risk factors.

  1981cites this paper
• Thromboxane Generation in Patients with Essential Hypertension or Cerebrovascular Disease and Effect of Oral Aspirin

  1980cites this paper
• Circulating platelet aggregates: a chronic platelet activation in patients with transient ischaemic attacks

  1979cites this paper
• Platelet Function Studies in Heart Disease: VI. Enhanced Platelet Aggregate Formation Activity in Congestive Heart Failure Inhibition by Sodium Nitroprusside

  1979cites this paper
• Differences in platelet aggregation in coronary sinus and aortic blood in patients with coronary artery disease: Effect of propranolol

  1978cites this paper